Awad, M.M., Gadgeel, S.M., Borghaei, H., Patnaik, A., Yang, J.C.H., Powell, S.F., Gentzler, R.D., Martins, R.G., Stevenson, J.P., Altan, M., et al. (2021).Long-term overall survival from KEYNOTE-021 cohort G: pemetrexed and car-boplatin with or without pembrolizumab as ﬁrst-line therapy for advanced non-squamous NSCLC. J.